These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 30021382

  • 1. MiR-373-3p enhances the chemosensitivity of gemcitabine through cell cycle pathway by targeting CCND2 in pancreatic carcinoma cells.
    Hu W, Liu Q, Pan J, Sui Z.
    Biomed Pharmacother; 2018 Sep; 105():887-898. PubMed ID: 30021382
    [Abstract] [Full Text] [Related]

  • 2. miR-125a-3p is responsible for chemosensitivity in PDAC by inhibiting epithelial-mesenchymal transition via Fyn.
    Liu G, Ji L, Ke M, Ou Z, Tang N, Li Y.
    Biomed Pharmacother; 2018 Oct; 106():523-531. PubMed ID: 29990840
    [Abstract] [Full Text] [Related]

  • 3. MiR-9-3p regulates the biological functions and drug resistance of gemcitabine-treated breast cancer cells and affects tumor growth through targeting MTDH.
    Wang Y, Dong L, Wan F, Chen F, Liu D, Chen D, Long J.
    Cell Death Dis; 2021 Sep 22; 12(10):861. PubMed ID: 34552061
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-29c Increases the Chemosensitivity of Pancreatic Cancer Cells by Inhibiting USP22 Mediated Autophagy.
    Huang L, Hu C, Cao H, Wu X, Wang R, Lu H, Li H, Chen H.
    Cell Physiol Biochem; 2018 Sep 22; 47(2):747-758. PubMed ID: 29807360
    [Abstract] [Full Text] [Related]

  • 5. Long non-coding RNA LINC00346 promotes pancreatic cancer growth and gemcitabine resistance by sponging miR-188-3p to derepress BRD4 expression.
    Shi W, Zhang C, Ning Z, Hua Y, Li Y, Chen L, Liu L, Chen Z, Meng Z.
    J Exp Clin Cancer Res; 2019 Feb 06; 38(1):60. PubMed ID: 30728036
    [Abstract] [Full Text] [Related]

  • 6. Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210.
    Yang Z, Zhao N, Cui J, Wu H, Xiong J, Peng T.
    Cell Oncol (Dordr); 2020 Feb 06; 43(1):123-136. PubMed ID: 31713003
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-29a induces resistance to gemcitabine through the Wnt/β-catenin signaling pathway in pancreatic cancer cells.
    Nagano H, Tomimaru Y, Eguchi H, Hama N, Wada H, Kawamoto K, Kobayashi S, Mori M, Doki Y.
    Int J Oncol; 2013 Oct 06; 43(4):1066-72. PubMed ID: 23900458
    [Abstract] [Full Text] [Related]

  • 8. Leptin-elicited miRNA-342-3p potentiates gemcitabine resistance in pancreatic ductal adenocarcinoma.
    Ma L, Fan Z, Du G, Wang H.
    Biochem Biophys Res Commun; 2019 Feb 12; 509(3):845-853. PubMed ID: 30638935
    [Abstract] [Full Text] [Related]

  • 9. MGMT expression affects the gemcitabine resistance of pancreatic cancer cells.
    Shi Y, Wang Y, Qian J, Yan X, Han Y, Yao N, Ma J.
    Life Sci; 2020 Oct 15; 259():118148. PubMed ID: 32721465
    [Abstract] [Full Text] [Related]

  • 10. miRNA-93-5p Promotes Gemcitabine Resistance in Pancreatic Cancer Cells by Targeting the PTEN-Mediated PI3K/Akt Signaling Pathway.
    Wu Y, Xu W, Yang Y, Zhang Z.
    Ann Clin Lab Sci; 2021 May 15; 51(3):310-320. PubMed ID: 34162560
    [Abstract] [Full Text] [Related]

  • 11. circACTR2 attenuates gemcitabine chemoresiatance in pancreatic cancer through PTEN mediated PI3K/AKT signaling pathway.
    Xu C, Ye Q, Ye C, Liu S.
    Biol Direct; 2023 Mar 30; 18(1):14. PubMed ID: 36991449
    [Abstract] [Full Text] [Related]

  • 12. The role of lncRNA MSC-AS1/miR-29b-3p axis-mediated CDK14 modulation in pancreatic cancer proliferation and Gemcitabine-induced apoptosis.
    Sun Y, Wang P, Yang W, Shan Y, Zhang Q, Wu H.
    Cancer Biol Ther; 2019 Mar 30; 20(6):729-739. PubMed ID: 30915884
    [Abstract] [Full Text] [Related]

  • 13. TIMP1 down-regulation enhances gemcitabine sensitivity and reverses chemoresistance in pancreatic cancer.
    Tan Y, Li X, Tian Z, Chen S, Zou J, Lian G, Chen S, Huang K, Chen Y.
    Biochem Pharmacol; 2021 Jul 30; 189():114085. PubMed ID: 32522594
    [Abstract] [Full Text] [Related]

  • 14. Long non-coding SBF2-AS1 acting as a competing endogenous RNA to sponge microRNA-142-3p to participate in gemcitabine resistance in pancreatic cancer via upregulating TWF1.
    Hua YQ, Zhu YD, Xie GQ, Zhang K, Sheng J, Zhu ZF, Ning ZY, Chen H, Chen Z, Meng ZQ, Liu LM.
    Aging (Albany NY); 2019 Nov 04; 11(20):8860-8878. PubMed ID: 31619579
    [Abstract] [Full Text] [Related]

  • 15. Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205.
    Chaudhary AK, Mondal G, Kumar V, Kattel K, Mahato RI.
    Cancer Lett; 2017 Aug 28; 402():1-8. PubMed ID: 28536008
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of metformin enhancing the sensitivity of human pancreatic cancer cells to gem-citabine by regulating the PI3K/Akt/mTOR signaling pathway.
    Zhou HY, Yao XM, Chen XD, Tang JM, Qiao ZG, Wu XY.
    Eur Rev Med Pharmacol Sci; 2019 Dec 28; 23(23):10283-10289. PubMed ID: 31841183
    [Abstract] [Full Text] [Related]

  • 17. SNHG14 enhances gemcitabine resistance by sponging miR-101 to stimulate cell autophagy in pancreatic cancer.
    Zhang X, Zhao P, Wang C, Xin B.
    Biochem Biophys Res Commun; 2019 Mar 19; 510(4):508-514. PubMed ID: 30737032
    [Abstract] [Full Text] [Related]

  • 18. Hyperthermia inhibits the motility of gemcitabine-resistant pancreatic cancer PANC-1 cells through the inhibition of epithelial-mesenchymal transition.
    Jin H, Zhao Y, Zhang S, Yang J, Zhang X, Ma S.
    Mol Med Rep; 2018 May 19; 17(5):7274-7280. PubMed ID: 29568909
    [Abstract] [Full Text] [Related]

  • 19. CXCR4/Let-7a Axis Regulates Metastasis and Chemoresistance of Pancreatic Cancer Cells Through Targeting HMGA2.
    Xiao G, Wang X, Yu Y.
    Cell Physiol Biochem; 2017 May 19; 43(2):840-851. PubMed ID: 28954272
    [Abstract] [Full Text] [Related]

  • 20. MiR-20a-5p regulates gemcitabine chemosensitivity by targeting RRM2 in pancreatic cancer cells and serves as a predictor for gemcitabine-based chemotherapy.
    Lu H, Lu S, Yang D, Zhang L, Ye J, Li M, Hu W.
    Biosci Rep; 2019 May 31; 39(5):. PubMed ID: 30777929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.